By integrating the clinical information data of early breast cancer, the distribution differences of RiskScore among different clinical information were analyzed, and the results shown that RiskScore showed significant differences among dead, ER, HER2, and PR (Figure 5A). This evidence concerns the gene ERBB2 and breast cancer.